MetS Risk Score: A Clear Scoring Model to Predict a 3-Year Risk for Metabolic Syndrome

Author:

Zou Tian-Tian12,Zhou Yu-Jie13,Zhou Xiao-Dong4,Liu Wen-Yue5,Van Poucke Sven6,Wu Wen-Jun5,Zheng Ji-Na13,Gu Xue-Mei5,Zhang Dong-Chu7,Zheng Ming-Hua18,Pan Xiao-Yan5

Affiliation:

1. Department of Hepatology, Liver Research Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China

2. School of the Second Clinical Medical Sciences, Wenzhou Medical University, Wenzhou, China

3. School of the First Clinical Medical Sciences, Wenzhou Medical University, Wenzhou, China

4. Department of Cardiovascular Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China

5. Department of Endocrinology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China

6. Department of Anesthesiology, Ziekenhuis Oost-Limburg, Genk, Belgium

7. Wenzhou Medical Center, Wenzhou People’s Hospital, Wenzhou, China

8. Institute of Hepatology, Wenzhou Medical University, Wenzhou, China

Abstract

AbstractAlthough several risk factors for metabolic syndrome (MetS) have been reported, there are few clinical scores that predict its incidence. Therefore, we created and validated a risk score for prediction of 3-year risk for MetS. Three-year follow-up data of 4395 initially MetS-free subjects, enrolled for an annual physical examination from Wenzhou Medical Center were analyzed. Subjects at enrollment were randomly divided into the training and the validation cohort. Univariate and multivariate logistic regression models were employed for model development. The selected variables were assigned an integer or half-integer risk score proportional to the estimated coefficient from the logistic model. Risk scores were tested in a validation cohort. The predictive performance of the model was tested by computing the area under the receiver operating characteristic curve (AUROC). Four independent predictors were chosen to construct the MetS risk score, including BMI (HR=1.906, 95% CI: 1.040–1.155), FPG (HR=1.507, 95% CI: 1.305–1.741), DBP (HR=1.061, 95% CI: 1.002–1.031), HDL-C (HR=0.539, 95% CI: 0.303–0.959). The model was created as –1.5 to 4 points, which demonstrated a considerable discrimination both in the training cohort (AUROC=0.674) and validation cohort (AUROC=0.690). Comparison of the observed with the estimated incidence of MetS revealed satisfactory precision. We developed and validated the MetS risk score with 4 risk factors to predict 3-year risk of MetS, useful for assessing the individual risk for MetS in medical practice.

Publisher

Georg Thieme Verlag KG

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,General Medicine,Endocrinology, Diabetes and Metabolism

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3